ALS

FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis

By September 06, 2018

The FDA approval was supported by data from bioavailability studies comparing riluzole tablets and Tiglutik oral suspension.

Radicava Now Available for the Treatment of ALS

By August 08, 2017

Radicava is supplied as a 30mg/100mL solution for intravenous infusion in single-dose polypropylene bags.

ALS, Parkinson's Mortality Tied to Certain Occupations

July 14, 2017

Occupations associated with higher education and income show increased mortality risk